These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 18802946)

  • 1. The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors.
    Kim A; Ji L; Balmaceda C; Diez B; Kellie SJ; Dunkel IJ; Gardner SL; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2008 Dec; 51(6):768-73. PubMed ID: 18802946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
    Habuchi T; Kamoto T; Hara I; Kawai K; Nakao M; Nonomura N; Kobayashi T; Ogawa O; Kamidono S; Akaza H; Okuyama A; Kato T; Miki T
    Cancer; 2003 Oct; 98(8):1635-42. PubMed ID: 14534879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.
    Kobayashi T; Kawakita M; Terachi T; Habuchi T; Ogawa O; Kamoto T
    J Surg Oncol; 2006 Dec; 94(7):619-23. PubMed ID: 17111392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secreting germ cell tumors of the central nervous system (CNS). First results of the cooperative German/Italian pilot study (CNS sGCT).
    Calaminus G; Andreussi L; Garré ML; Kortmann RD; Schober R; Göbel U
    Klin Padiatr; 1997; 209(4):222-7. PubMed ID: 9293454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.
    Khatua S; Dhall G; O'Neil S; Jubran R; Villablanca JG; Marachelian A; Nastia A; Lavey R; Olch AJ; Gonzalez I; Gilles F; Nelson M; Panigrahy A; McComb G; Krieger M; Fan J; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2010 Jul; 55(1):42-6. PubMed ID: 20222020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment.
    Murugaesu N; Schmid P; Dancey G; Agarwal R; Holden L; McNeish I; Savage PM; Newlands ES; Rustin GJ; Seckl MJ
    J Clin Oncol; 2006 Oct; 24(30):4862-6. PubMed ID: 17050871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant ovarian germ cell tumors: clinico-pathological presentation and survival outcomes.
    Tangjitgamol S; Hanprasertpong J; Manusirivithaya S; Wootipoom V; Thavaramara T; Buhachat R
    Acta Obstet Gynecol Scand; 2010; 89(2):182-9. PubMed ID: 19961281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors.
    Toner GC; Geller NL; Tan C; Nisselbaum J; Bosl GJ
    Cancer Res; 1990 Sep; 50(18):5904-10. PubMed ID: 1697503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary chemotherapy for intracranial germ cell tumors: results of the third international CNS germ cell tumor study.
    da Silva NS; Cappellano AM; Diez B; Cavalheiro S; Gardner S; Wisoff J; Kellie S; Parker R; Garvin J; Finlay J
    Pediatr Blood Cancer; 2010 Mar; 54(3):377-83. PubMed ID: 20063410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection.
    Beck SD; Foster RS; Bihrle R; Einhorn LH; Donohue JP
    J Clin Oncol; 2005 Sep; 23(25):6149-56. PubMed ID: 16135481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Improved prognosis of intracranial germ cell tumors by intensified therapy: results of the MAKEI 89 therapy protocol].
    Göbel U; Bamberg M; Calaminus G; Gnekow AK; Herrmann HD; Lenard HG; Spaar HJ; Niethammer D; Kühl J; Harms D
    Klin Padiatr; 1993; 205(4):217-24. PubMed ID: 7690863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors?
    Gerl A; Lamerz R; Clemm C; Mann K; Hartenstein R; Wilmanns W
    Clin Cancer Res; 1996 Sep; 2(9):1565-70. PubMed ID: 9816334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumors.
    Fizazi K; Culine S; Kramar A; Amato RJ; Bouzy J; Chen I; Droz JP; Logothetis CJ
    J Clin Oncol; 2004 Oct; 22(19):3868-76. PubMed ID: 15302906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Germ-cell tumors of the central nervous system in childhood: retrospective study of 13 patients].
    Voirin J; Klein O; Chastagner P; Moret C; Vignaud JM; Auque J; Marchal JC
    Neurochirurgie; 2008 Apr; 54(2):55-62. PubMed ID: 18355878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of alpha 1-fetoprotein and beta-human chorionic gonadotropin in infancy and childhood.
    Schneider DT; Calaminus G; Göbel U
    Pediatr Hematol Oncol; 2001; 18(1):11-26. PubMed ID: 11205836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical treatment of malignant mediastinal nonseminomatous germ cell tumor.
    Kang CH; Kim YT; Jheon SH; Sung SW; Kim JH
    Ann Thorac Surg; 2008 Feb; 85(2):379-84. PubMed ID: 18222229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in metastatic nonseminomatous germ cell tumours.
    Hanson PR; Belitsky P; Millard OH; Lannon SG
    Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of intracranial germinoma with hCG elevation in cerebrospinal fluid but not in serum.
    Utsuki S; Oka H; Tanaka S; Tanizaki Y; Fujii K
    Acta Neurochir (Wien); 2002 Nov; 144(11):1151-4; discussion 1154-5. PubMed ID: 12434171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of ventricular tumor markers in CNS germ cell tumors.
    Legault G; Allen JC
    Pediatr Blood Cancer; 2013 Oct; 60(10):1647-50. PubMed ID: 23788492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of intracranial immature teratoma.
    Huang X; Zhang R; Zhou LF
    Pediatr Neurosurg; 2009; 45(5):354-60. PubMed ID: 19907199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.